| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. | Ann Rheum Dis | 2008 | 2.21 |
| 2 | Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health. | Arthritis Rheum | 2006 | 1.59 |
| 3 | Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. | Arthritis Care Res (Hoboken) | 2010 | 1.15 |
| 4 | The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis. | Ann Rheum Dis | 2008 | 1.00 |